Warning: Attempt to read property "taxonomy" on null in /srv/users/projectals/apps/projectals-prod/public/wp-content/plugins/seo-by-rank-math/includes/frontend/paper/class-taxonomy.php on line 49
Warning: Attempt to read property "taxonomy" on null in /srv/users/projectals/apps/projectals-prod/public/wp-content/plugins/seo-by-rank-math/includes/frontend/paper/class-taxonomy.php on line 54
Warning: Attempt to read property "taxonomy" on null in /srv/users/projectals/apps/projectals-prod/public/wp-content/plugins/seo-by-rank-math/includes/class-term.php on line 110 Skip to content
In order to prevent, treat, or cure diseases, scientists rely on methods for identifying consistent mechanisms behind disease, and efficiently testing potential therapies on a
In 2020, Cathy and Richard called Project ALS after hearing about the development of a novel antisense oligonucleotide (ASO) therapy for people living with FUS ALS. So was born NextGen ALS, a Weber family initiative in collaboration with Project ALS that is committed to raising funds for targeted research toward treatments and cures for genetic forms of ALS.
Project ALS was lucky to join five other ALS organizations at the first in-person meeting of the ALS Collaborative Cohort to discuss issues of access and inclusion within the ALS community
Researchers from the Project ALS Therapeutics Core at Columbia (the Core), in a groundbreaking collaborative effort with Ionis Pharmaceuticals, have developed a new tool for studying ALS mechanisms and therapies, as well as a novel approach for treating ALS caused by mutations…